breadcrumb-bg

Discover the future of cancer drug design

Bioinnovation —

Vision and objectives

KAUST Smart-Health Initiative (KSHI) aims to operate as an incubator to accelerate research innovation in life science, biology, AI, precision medicine and drive the development of new solutions by early-stage life science start-ups and promote entrepreneurship initiatives from junior and senior scientist from KAUST and beyond.

 

 

Latest achievements

Discover the future of cancer drug design

11 October, 2023

In an article published on Pharmafile.com, KAUST Professor Lukasz Jaremko delves into the promising realm of targeted cancer drug design.

Why destroy when we can repair? Professor Jaremko's expert opinion explores the unprecedented potential of structural biology integrating biomolecular dynamics probed by nuclear magnetic resonance (NMR)  to study epigenetic targets, offering a fresh perspective on cancer treatment for the pharmaceutical industry.

Read the full article here: https://magazine.pharmafile.com/articles/repairing-not-destroying-the-future-of-targeted-cancer-drug-des